Your browser doesn't support javascript.
loading
Phase 1/2 study evaluating the safety and efficacy of DSP-7888 dosing emulsion in myelodysplastic syndromes.
Ueda, Yasunori; Usuki, Kensuke; Fujita, Jiro; Matsumura, Itaru; Aotsuka, Nobuyuki; Sekiguchi, Naohiro; Nakazato, Tomonori; Iwasaki, Hiromi; Takahara-Matsubara, Mariko; Sugimoto, Saori; Goto, Masashi; Naoe, Tomoki; Kizaki, Masahiro; Miyazaki, Yasushi; Aakashi, Koichi.
Affiliation
  • Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Okayama, Japan.
  • Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Fujita J; Department of Hematology and Oncology, Osaka University Hospital, Osaka, Japan.
  • Matsumura I; Department of Hematology and Rheumatology, Kindai University Hospital, Osaka, Japan.
  • Aotsuka N; Department of Hematology Oncology, Japanese Red Cross Narita Hospital, Chiba, Japan.
  • Sekiguchi N; Department of Hematology, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
  • Nakazato T; Department of Hematology, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan.
  • Iwasaki H; Department of Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Takahara-Matsubara M; Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan.
  • Sugimoto S; Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan.
  • Goto M; Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan.
  • Naoe T; National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Kizaki M; Department of Hematology, Saitama Medical Center, Saitama, Japan.
  • Miyazaki Y; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Aakashi K; Department of Medicine and Biosystemic Science Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Cancer Sci ; 113(4): 1377-1392, 2022 Apr.
Article in En | MEDLINE | ID: mdl-34932235

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Cancer Vaccines Limits: Humans Language: En Journal: Cancer Sci Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Cancer Vaccines Limits: Humans Language: En Journal: Cancer Sci Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom